Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
AT&S Austria Technologie & Systemtechnik AG

Start price
Target price
Perf. (%)
€35.60
19.09.21
€60.00
19.09.22
28.37%
16.06.22

buy
Coupang Inc.

Start price
Target price
Perf. (%)
€24.85
19.09.21
€33.00
19.09.22
-4.99%
02.10.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Tomtom N.v.

Start price
Target price
Perf. (%)
€3.28
19.09.21
€5.00
19.09.22
-0.05%
02.10.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Ceotronics AG

Start price
Target price
Perf. (%)
€4.59
19.09.21
€8.00
19.09.22
-3.05%
02.10.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Alibaba Group Holding Ltd ADR

Start price
Target price
Perf. (%)
€135.10
19.09.21
-
19.09.22
-33.72%
15.09.22

Probably not worthwhile Investment
Increased challenges to pay loans and raise capital
High risks in the balance sheet
High risks for its business
buy
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€2.07
19.09.21
-
19.09.22
21.26%
02.10.21

Risky Investment
buy
51 Talk Online Education Group ADR

Start price
Target price
Perf. (%)
€9.36
19.09.21
-
19.09.22
-10.26%
02.10.21

Risky Investment
buy
TAL Education Group ADR

Start price
Target price
Perf. (%)
€3.78
19.09.21
-
19.09.22
5.82%
02.10.21

Risky Investment
buy
New Oriental Education & Technology Group

Start price
Target price
Perf. (%)
€1.54
19.09.21
-
19.09.22
14.29%
02.10.21

Risky Investment
buy
New Oriental Education & Technology Group ADR

Start price
Target price
Perf. (%)
€15.80
19.09.21
-
19.09.22
13.92%
02.10.21

Risky Investment
buy
Nordex SE ADR

Start price
Target price
Perf. (%)
€7.50
19.09.21
-
19.09.22
1.33%
27.11.21

Could be worthwhile Investment >10% per year
High valuation
MacroGenics Inc.

Start price
Target price
Perf. (%)
€16.79
19.09.21
-
19.09.22
-79.51%
20.09.22

Probably not worthwhile Investment
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.05
19.09.21
-
19.09.22
-85.23%
20.09.22

Growths faster than the competition
Risky Investment
Celyad SA ADR

Start price
Target price
Perf. (%)
€3.58
19.09.21
-
19.09.22
-53.35%
20.09.22

Probably not worthwhile Investment
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.53
19.09.21
-
19.09.22
-75.74%
20.09.22

Probably not worthwhile Investment
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€5.30
18.09.21
-
18.09.22
-63.56%
19.09.22

Risky Investment
High risks for its business
Dependend from few customers or products
buy
Blackrock I-br Adv.eu. Equ.

Start price
Target price
Perf. (%)
€126.55
18.09.21
-
18.09.22
-2.66%
19.09.22

Could be worthwhile Investment >10% per year
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
18.09.21
€10.00
31.12.23
-79.42%
08.05.23

Could be very worthwhile Investment >20% year
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€12.54
18.09.21
€20.00
31.12.23
-52.05%
08.05.23

Could be very worthwhile Investment >20% year
buy
Spectrum Pharmaceuticals

Start price
Target price
Perf. (%)
€2.60
18.09.21
€5.00
31.12.23
-62.67%
08.05.23

Could be very worthwhile Investment >20% year
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.20
18.09.21
€40.00
31.12.23
61.97%
16.12.21

Could be very worthwhile Investment >20% year
buy
ASLAN Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€13.30
18.09.21
€20.00
31.12.23
-76.88%
08.05.23

Could be very worthwhile Investment >20% year
Innate Pharma

Start price
Target price
Perf. (%)
€6.61
18.09.21
€3.00
18.09.22
-22.01%
02.10.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€6.60
18.09.21
€3.00
18.09.22
-26.06%
02.10.21

Lower EBIT Margin than peer group
Bad rating
Increased challenges to pay loans and raise capital
Below average Management
micromobility.com Inc.

Start price
Target price
Perf. (%)
€693.90
18.09.21
€350.00
18.09.22
-22.18%
02.10.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Low dividend yield expected